Inflammatory myopathies

Patient-Reported Outcome Measurement Information System (PROMIS) displays strong construct validity in pediatric and adult patients with idiopathic inflammatory myopathies

Rheumatology (Oxford)Published Cross-sectional study

Authors' conclusion

PROMIS offers a nuanced view of HRQoL that traditional disease assessments do not adequately capture. PROMIS has good construct validity and it may be more sensitive than legacy HRQoL measures.

Study context

Population
Pediatric and adult patients with juvenile and adult-onset IIM (JIIM/IIM), and parents
Participants
70 / 49 / 61
Exposure
Parents vs Pediatric vs Adult
  • Parentsn = 70
  • Pediatricn = 49
  • Adultn = 61
Outcome
Construct validity of PROMIS against legacy HRQoL instruments and associations with disease assessments and clinical characteristics
Methodological detailsvalidation study
  • Validation study

Main finding

As reported in the abstract

Decreased Physical Function vs reference population, all groups
39.9-44.3, P < 0.001-0.002
Increased pain interference, all groups
49.6-55.8, P < 0.001
Increased fatigue, all groups
49.5-55.1, P < 0.001-0.004
Increased anxiety, all groups
47.0-52.5, P < 0.001-0.043
Internal consistency, excellent
α > 0.9

Observational data: associations, not effects.

Further findings

OutcomeEstimateP value
Parent vs child report: PF, Fatigue, AnxietyParents vs Pediatric · worse PF reported by parentsPF score 39.7 vs 42.9P < 0.001
Parent vs child report: PF, Fatigue, AnxietyParents vs Pediatric · more fatigue reported by parentsFatigue score 52.4 vs 48.5P = 0.023
Parent vs child report: PF, Fatigue, AnxietyParents vs Pediatric · higher anxiety reported by parentsAnxiety score 49.6 vs 46.8P = 0.032

Correlation with disease activity and damage

PROMIS Physical Function (PF) correlated best with disease activity measures
|r|=0.022-0.636
Only parent PF correlated with Physician Global Damage
|r|=0.414
Social Role, Anxiety and Depression correlated poorly with disease activity measures
Several PROMIS domains correlated better with disease assessments than SF-36

Original publication

PROMIS displays strong construct validity in pediatric and adult patients with idiopathic inflammatory myopathies. Rheumatology (Oxford). Published 25 September 2025. doi:10.1093/rheumatology/keaf502

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.